In-Person Access Only | 8.75 CE/CME Credits & MOC Points
Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com
We invite you to join us for the 4th Annual Best of Hematology conference. This innovative and state of the art program will feature some of the world's leading hematologists to present the latest research and strategies for the care of hematological malignancies — incorporating data from the major oncologic annual meetings.
Program Chairs:
Ajay Major, MD (University of Colorado Anschutz)
Erin Schwab, MD (Vail Health/Shaw Cancer Center)
Conference Agenda
Saturday, February 6, 2027
7:15 AM
Registration Opens
7:45 AM
Breakfast and Exhibits
8:15 AM
Non-CME Breakfast
9:00 AM
Welcome and Opening Remarks
9:30 AM
Acute Leukemias in 2027: MRD-Guided Therapy, Cellular Immunotherapy, and Emerging Treatment Strategies in AML and ALL
Chelby Wakefield, MD | Banner Health
10:00 AM
CLL: Fixed-Duration Therapy, BTK Degraders, and Treatment Sequencing
Steven Bair, MD | University of Colorado Anschutz
10:30 AM
Coffee Break and Networking
10:40 AM
DLBCL Beyond R-CHOP: How Are Bispecifics and CAR-T Moving Earlier?
Joseph Tuscano, MD | UC Davis
11:10 AM
Follicular and Indolent Lymphomas: When to Use Bispecifics, CAR-T, and Novel Immune Therapies
Ajay Major, MD | University of Colorado Anschutz
11:40 AM
Operationalizing Bispecific Antibody Programs Across Community and Academic Programs
Bilal Abid, MD | Texas Tech University Health Science Center
12:10 PM
Housekeeping and Survey
12:20 PM
Lunch and Exhibits
12:40 PM
Non-CME Lunch
1:25 PM
Coffee Break and Networking
1:55 PM
Panel Discussion: Practice-Changing Hematology Abstracts 2026-2027: What Will Change Monday Morning?
Ajay Major, MD (Moderator) | University of Colorado Anschutz
Joseph Tuscano, MD | UC Davis
Bilal Abid, MD | Texas Tech University Health Science Center
Chelby Wakefield, MD | Banner Health
Steven Bair, MD | University of Colorado Anschutz
2:55 PM
ADJOURN
Sunday, February 7, 2027
7:15 AM
Registration Opens
7:45 AM
Breakfast and Exhibits
8:15 AM
Non-CME Breakfast
9:00 AM
Welcome and Opening Remarks
9:30 AM
Navigating Rare Hematologic Malignancies: Current Approaches to Systemic Mastocytosis, PTLD, and CNS Lymphomas
Cassandra Duarte, MD | University of Colorado Anschutz
10:00 AM
Multiple Myeloma: Sequencing BCMA and GPRC5D Therapies in Clinical Practice
Peter Forsberg, MD | Colorado Blood Cancer Institute
10:30 AM
Coffee Break and Networking
10:40 AM
Multiple Myeloma: Promise and Pitfalls of Time Limited Therapy
Tim Schmidt, MD | University of Wisconsin
11:10 AM
MDS and MPNs: New Standards of Care and Emerging Disease-Modifying Strategies
11:40 AM
Benign Hematology in 2027: Gene Therapy, Gene Editing, and Curative Approaches
Erin Schwab, MD (Program Co-Chair) | Vail Health/Shaw Cancer Center
12:10 PM
Housekeeping and Survey
12:20 PM
Lunch and Exhibits
12:40 PM
Non-CME Lunch
1:25 PM
Coffee Break and Networking
1:55 PM
Panel Discussion: How Are You Actually Integrating Novel Hematology Therapies Into Practice?
Erin Schwab, MD (Moderator) | Vail Health/Shaw Cancer Center
Cassandra Duarte, MD | University of Colorado Anschutz
Tim Schmidt, MD | University of Wisconsin
Peter Forsberg, MD | Colorado Blood Cancer Institute
2:55 PM
ADJOURN
Agenda Subject To Change. All times are MST.
-
Apply the current standards of oncology care and key updates from national clinical guidance pathways to optimize the management of patients with various hematologic malignancies.
Review new, emerging, and novel therapeutic agents and treatment strategies and incorporate these into the management of patients with hematologic malignancies.
Communicate with members of the interprofessional oncology care team to improve collaborative performance in the management of patients with hematologic malignancies.
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 7.50 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 7.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 7.50 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 45 days of the activity to meet the deadline for submission to PARS.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program